newsfilter
← Latest News
Business Wire·

CytRx to Participate in the H.C. Wainwright BioConnect Virtual Conference

CytRx Corporation (OTCQB:CYTR) ("CytRx" or the "Company"), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerative disease categories, today announced that John Caloz, the Company's Chief Financ